Daniel J. Levangie, President, Surgical Products at CYTYC CORP (CYTC), sold 30,000 shares at $26.90 ($807K) on 2006-11-07, disclosed to the SEC on 2006-11-07.
Scheduled sale ($807k) by President, Surgical Products under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EXAS | SELL | 2019-08-02 | $5.0M | — | Filing → |
| PODD | SELL | 2016-03-11 | $524K | — | Filing → |
| PODD | SELL | 2016-03-09 | $477K | — | Filing → |